Pasar al contenido principal

EXOSOMAS CATALITICOS COMO AGENTES TERAPEUTICOS. APLICACIONES ANTITUMORALES Y ANTIBACTERIANAS

PID2023-148732NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glutathione threshold-triggered selective breakability of organosilica nanocapsules

  • Mosseri, Andrea
  • Rueda-Flores, Ana
  • Hueso, José L.
  • Urriolabeitia, Esteban P.
  • De Cola, Luisa
  • Santamaría, Jesús
The data that support the findings of this study are available from the corresponding author upon reasonable request., This article also appears in: Catalytic Strategies for Therapy and Diagnosis. Society Volumes: Italy. Society Volumes: Spain., Biomolecules like proteins and enzymes can target and disrupt cancer cell pathways more specifically and with lower toxicity than traditional treatments. However, their lack of stability and methods for their effective delivery still present unsolved challenges. Silica nanocapsules have been proposed as carriers capable of protecting sensitive loads but their use is limited by their low biodegradability. For this reason, breakable silica structures, able to disassemble when exposed to representative levels of biomolecules readily available in the tumor microenvironment (TME), appear as ideal delivery vectors. In this work, we focus on the optimization of the synthesis parameters governing the breakability of organo-silica nanocapsules containing cleavable disulfide bonds. The objective is to trigger selective release in the presence of glutathione (GSH), a key molecule overexpressed in tumor cells. However, disulfide bonds can also be degraded in the presence of other molecules, which reduces the selectivity of delivery. We have modified the synthesis to obtain a response that leads to silica disassembly only when GSH levels are above a certain threshold, while remaining stable against other reductants, such as those present in standard extracellular culture media. The selection of the proper silica precursor was critical to obtain silica capsules that is able to disassemble and release Cytochrome C (CytC) upon exposure to GSH concentrations typical of those existing in the TME., The authors acknowledge financial support from the Spanish Ministry of Science, Innovation and Universities (FPI Ayuda PRE2022-104024 and Plan Nacional project CONCERT, PID2023-148732NB-I00). Luisa De Cola thanks the European Union´s Horizon 2020 research and innovation programme under grant agreement No 964386, project acronym “MimicKEY”. The synthesis of materials has been performed by the Platform of Production of Biomaterials and Nanoparticles of the NANBIOSIS ICTS, more specifically by the Nanoparticle Synthesis Unit (Unit 9) of the CIBER in BioEngineering, Biomaterials & Nanomedicine (CIBER-BBN). The TEM studies were conducted at the Laboratorio de Microscopias Avanzadas, Instituto de Nanociencia y Materiales de Aragon, Universidad de Zaragoza, Spain. (SAI and ELECMI). Ayuda CEX2023-001286-S financiada por MICIU/AEI /10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell-driven encapsulation of chlorophyllin-based carbon dots within exosomes for enhanced photodynamic therapy: miRNA profiling reveals mechanistic insights

  • Besbinar, Omur
  • Martín-Pardillos, Ana
  • Hueso, José L.
  • Santamaría, Jesús
  • Yilmazer, Açelya
et al., Exosomes, nanoscale extracellular vesicles, have emerged as promising carriers in drug delivery due to their ability to bypass biological barriers, low toxicity, high stability, and intrinsic targeting capabilities. Mesenchymal stem-cell-derived exosomes (EXOMSC), with their natural tropism toward the tumor microenvironment, offer an ideal platform for enhancing therapeutic cargo delivery. In this study, we demonstrate an approach where red-emission chlorophyll-based carbon dots (Chl-CDs) were encapsulated within EXOMSC through a cell-driven uptake mechanism, creating CD@EXOMSC. These exosomes achieved superior photodynamic therapy (PDT) efficacy, requiring 40 times less nanomaterial compared to freestanding Chl-CDs. Mechanistic insights from glioblastoma cell miRNA profiling revealed that the enhanced efficacy was mediated by the regulation of efflux transporter genes, oxidative stress responses, and endocytosis pathways. This work highlights the synergistic potential of combining photosensitizers and miRNA-rich exosomes to achieve targeted and sustained therapeutic delivery, paving the way for a multifaceted approach in cancer therapy., O.B. expresses gratitude to the Council of Higher Education (YOK) for the YOK100/2000 Ph.D. scholarship and to the Scientific and Technological Research Council of Turkey (TUBITAK) for the 2214-A PhD. International Research Scholarship. A.Y. acknowledges funding from the European Union’s Horizon Europe program, under the Marie Sklodowska-Curie grant agreement No. 101086184 (MX-MAP). J.L.H. and J.S. acknowledge the Spanish Research Agency and MICN/AEI (CNS2022-135911), the Government of Aragon (Group T57_23R) and CIBER-BBN. Ayuda Severo Ochoa CEX2023-001286-S financiada por MICIU/AEI/10.13039/501100011033 is also acknowledged. J.S., A.M.P., and J.L.H. acknowledge funding from Ministerio de Ciencia, Innovación y Universidades, Project CONCERT, PID2023-148732NB-I00., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanomedical approaches to deplete intracellular glutathione in oncology

  • Bonet-Aleta, Javier
  • Hueso, José L.
  • Mosseri, Andrea
  • Santamaría, Jesús
Glutathione (GSH) plays a critical role in maintaining redox homeostasis and conferring chemoresistance to cancer cells, making it an attractive target for therapeutic intervention. Recent advances in nanomedicine have led to the development of diverse nanostructures capable of depleting GSH, either stoichiometrically or catalytically. These systems exploit the elevated GSH demand in tumors to selectively disrupt redox balance, enhancing reactive oxygen species (ROS) accumulation and improving the efficacy of conventional therapies. Approaches include metal-based nanocatalysts, GSH-responsive prodrugs, and stimuli-activated platforms using light or ultrasound for spatiotemporal control. Despite promising preclinical outcomes, key challenges remain, including limited mechanistic understanding, variability in GSH sensitivity across cancer types, and a lack of standardized assays to evaluate GSH-depleting efficiency. Addressing these gaps will require cross-disciplinary efforts bridging materials science, chemical biology, and catalysis. Such integration is essential for translating GSH-targeting nanomedicines into effective clinical tools against drug-resistant malignancies. This perspective provides an overview of some of the most promising nanomaterials explored in the current state of the art and discusses the main strategies and challenges relevant to future clinical translation., J. B.-A. acknowledges the Herchel–Smith Fund for financial support. The authors are thankful for funding from the Spanish Research Agency and MICN/AEI projects PID2023-148732NB-I00 and CNS2022-135911. Severo Ochoa funds (CEX2023-001286-S) from MICIU/AEI/10.13039/501100011033 are acknowledged. Financial support from Diputación General de Aragón under project T57_23R (Grupos Reconocidos) is acknowledged. CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN) and the Platform of Production of Biomaterials and Nanoparticles of the NANOBIOSIS ICTS are also acknowledged. The authors also thank the InterPHOT thematic network and “Conexion Fotocatalisis” CSIC hub., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An activity-based sensing approach to monitor nanomaterial-promoted vhanges in labile metal pools in living systems

  • Bonet-Aleta, Javier
  • Pezacki, Aidan T.
  • Oi, Miku
  • Hueso, José L.
  • Santamaría, Jesús
  • Chang, Christopher J.
Metal-based nanoparticles are a promising class of materials for diagnosis and treatment of cancer and other diseases. However, mechanisms of action of these nanomedicines remain insufficiently understood due in large part to our limited understanding of the dynamic equilibria between solid metal nanoparticles and labile metal ions generated from these nanoparticles within complex biological milieus. Here, we apply activity-based sensing to directly identify and investigate the fate of labile copper pools with metal and oxidation state-specificity generated by anticancer copper nanomedicines. We found that treatment of cells with copper-releasing nanoparticles alter labile Cu-(I)/Cu-(II) ratios through an increase in labile Cu-(II), while overall labile copper levels decrease. Labile copper release triggers compensatory responses in two major antioxidant pathways, glutathione (GSH) and nuclear factor erythroid 2-related factor 2 (NRF2), as well as in metal homeostasis to limit copper availability via regulation of copper export (ATP7B) and copper import (CTR1) proteins. These findings establish the value of activity-based sensing as a generalizable approach for labile metal imaging to help decipher molecular mechanisms of bioactive metal nanoparticles and guide the development of more effective nanomedicine diagnostics and therapies to target metal-dependent disease vulnerabilities., C.J.C. thanks the NIH (GM79465, GM139245, and ES 28096) and the U.S. Department of Energy, Office of Science, Office of Advanced Scientific Computing, Office of Basic Energy Sciences, via the Division of Chemical Sciences, Geosciences, and Bioscience of the U.S. Department of Energy at Lawrence Berkeley National Laboratory (Grant No. DEAC02-05CH11231) for support of the work. C.J.C. is a CIFAR Fellow. J.S. is thankful for the financial support from the European Research Council (ERC) Advanced Grant CADENCE number 742684. J.S. and J.L.H. acknowledge funding from the Spanish Research Agency (AEI) through Plan Nacional project CONCERT: PID2023-148732NB-I00 and Severo Ochoa Excellence Program: CEX2023-001286-S. J.B.A. acknowledges the Spanish Government for a FPU predoctoral contract. J.B.-A. acknowledges financial support from the Herchel Smith Fund., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Copper–collagen interactions regulate the mechanical and invasive properties of tumor spheroids

  • Guerrero-López, Paula
  • García-Peiro, José I.
  • Hornos, Felipe
  • Hueso, José L.
  • Santamaría, Jesús
  • García-Aznar, José Manuel
Copper is a key trace element with established cytotoxic properties, yet its interactions with the extracellular matrix and their implications for the evolution of 3D culture models remain poorly understood. Here, we study how copper entrapped in collagen can regulate the structural and invasive properties of 3D tumor spheroids. Our findings reveal that copper influences cytoskeletal organization, protrusion dynamics, and epithelial–mesenchymal transitions. Interestingly, we also highlight its dual capacity to either suppress or enhance invasive behavior depending on the context of exposure. These results position copper as a context-dependent modulator of tumor progression and underscore the importance of dose and timing in determining therapeutic outcomes. By integrating a physiologically relevant 3D model, this study provides new insights into copper–ECM interactions and identifies potential strategies to exploit them for cancer therapy., The authors also would like to acknowledge the European Research Council (ERC) for funding the Advanced Grant Agreement Catalytic Dual-Function Devices Against Cancer (CADENCE) project number 742684. PGL gratefully acknowledges the support of the Government of Aragon (grant no 2021–25). F.H. acknowledges the Generalitat Valenciana and the European Social Fund for an APOSTD fellowship (APOSTD/2021/196). The study was also supported by the Aragon Government via Research Groups T50_23R and T57_23R. Ayuda Severo Ochoa CEX2023-001286-S y CONCERT (PID2023-148732NB-I00) financiados por MICIU/AEI /10.13039/501100011033. Part of this work corresponding to PGL and JMGA was supported by the Scientific Foundation of the Spanish Association Against Cancer through the AECC 70% Survivorship Challenge – Call 2024 (RETOS245779LLOV),Project: ASPIRE-AECC., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ultrasmall platinum nanoparticles for radiation-enhanced cancer therapy

  • Encinas-Giménez, Miguel
  • García-Peiro, José I.
  • Hueso, José L.
  • Caleiras, Eduardo
  • Notario, Laura
  • Hornos, Felipe
  • Martín-Duque, Pilar
  • Vieja, Antonio de la
  • Santamaría, Jesús
Despite decades of intense research, cancer remains a major global health challenge, with a clear need for new and more efficient therapies. Among emerging approaches, high atomic number (Z) nanomaterials capable of modulating the interaction between radiation and matter have attracted growing interest as radiotherapy enhancers. In this work, ultra-small Platinum-based nanoparticles with a metallic core diameter of 2–3 nm were synthesized from H2PtCl6 using polyvinylpyrrolidone as stabilizer. This nanomaterial exhibits low acute toxicity, catalase-like activity and enhances DNA damage under pre-clinical X-ray irradiation, increasing the antitumoral effect of X-ray alone. In vitro and in vivo studies, including intratumoral and intravenous administration, demonstrate improved tumor control and prolonged survival without detectable systemic toxicity under the tested conditions, establishing ultra-small Pt-nanoparticles as efficient materials for radiotherapy enhancement., The authors would like to acknowledge funding from the ERC Advanced Grant CADENCE project number 742684 and from Spanish Government Grant PID2023-148732NB-100. A.D.L.V acknowledges the Spanish Government grant PID2021-125948OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER (UE) and P.M.D funding from Instituto de Salud Carlos lll, AESI 2024 PI24CIII/00046 and Ministerio de Ciencia, Innovación y Universidades. CNS2023-145442. The authors also thank CIBER-BBN, an initiative funded by the VI National R&D&i Plan 2008–2011 financed by the Instituto de Salud Carlos III (ISCIII) with the assistance of the European Regional Development Fund. M.E.G. and J.I.G.P. acknowledge the Aragon Regional Government for their predoctoral contracts. F.H. acknowledges the Generalitat Valenciana and the European Social Fund for an APOSTD fellowship (APOSTD/2021/196). The study was also supported by the Aragon Government via Research Group T57_23R. Severo Ochoa (CEX2023-001286-S) is acknowledged by MICIU/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular vesicles as nanoparticle delivery vectors in cancer therapy

  • Sancho‐Albero, María
  • Martín-Pardillos, Ana
  • Hueso, José L.
  • Sebastián, Víctor
  • Santamaría, Jesús
Three decades after the approval of the first cancer nanomedicine, low (<1%) tumor delivery remains the central unsolved challenge in nanoparticle (NP)-based therapy. This barrier has prompted a research shift toward biologically derived delivery systems able to reduce immune clearance while preserving tumor-homing capabilities. In particular, extracellular vesicles (EVs) seem obvious candidates on account of their intrinsic biocompatibility, cell-specific tropism, and biological functionality. In this mini-review, we critically analyze EVs as nanoparticle delivery vectors in cancer therapy. We describe current EV engineering approaches, including loading methodologies, surface modification strategies, and the development of artificial or biomimetic EVs, highlighting technical, scalability, and characterization challenges. We also summarize key in vitro and in vivo results, addressing encapsulation strategy, biodistribution, and therapeutic outcomes. From this discussion, we outline research needs that must be addressed to develop EV–NP hybrids as tools to overcome the delivery challenge in cancer., Authors are thankful for the support from the Spanish Ministry of Science, Innovation and Universities from the Spanish Government (grants PID2023-148732NB-I00 and PID2024-160339OB-I00), the European Research Council (ERC-Advanced Grant ROMEO number 101201543), and Severo Ochoa Excellence Program: CEX2023-001286-S. M.S.-A. acknowledges the Spanish Ministry of Science, Innovation and Universities from the Spanish Government a Ramón y Cajal Fellowship (RYC2024-050017-I)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Glutathione Threshold‐Triggered Selective Breakability of Organosilica Nanocapsules

  • Mosseri, Andrea
  • Rueda-Flores, Ana
  • Hueso, Jose L.
  • Urriolabeitia, Esteban
  • De Cola, Luisa
  • Santamaria, Jesus
Biomolecules like proteins and enzymes can target and disrupt cancer cell pathways more specifically and with lower toxicity than traditional treatments. However, their lack of stability and methods for their effective delivery still present unsolved challenges. Silica nanocapsules have been proposed as carriers capable of protecting sensitive loads but their use is limited by their low biodegradability. For this reason, breakable silica structures, able to disassemble when exposed to representative levels of biomolecules readily available in the tumor microenvironment (TME), appear as ideal delivery vectors. In this work, we focus on the optimization of the synthesis parameters governing the breakability of organo‐silica nanocapsules containing cleavable disulfide bonds. The objective is to trigger selective release in the presence of glutathione (GSH), a key molecule overexpressed in tumor cells. However, disulfide bonds can also be degraded in the presence of other molecules, which reduces the selectivity of delivery. We have modified the synthesis to obtain a response that leads to silica disassembly only when GSH levels are above a certain threshold, while remaining stable against other reductants, such as those present in standard extracellular culture media. The selection of the proper silica precursor was critical to obtain silica capsules that is able to disassemble and release Cytochrome C (CytC) upon exposure to GSH concentrations typical of those existing in the TME.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cell-Driven Encapsulation of Chlorophyllin-Based Carbon Dots within Exosomes for Enhanced Photodynamic Therapy: miRNA Profiling Reveals Mechanistic Insights

  • Besbinar, Omur
  • Uyar, Recep
  • Kirbas Cilingir, Emel
  • Martín-Pardillos, Ana
  • Hueso, Jose L.
  • Ceylan, Ahmet
  • Ozgenc, Ozge
  • Ekim, Okan
  • Unal, Mehmet Altay
  • Ari, Fikret
  • Leblanc, Roger M.
  • Santamaria, Jesus
  • Yilmazer, Acelya
Exosomes, nanoscale extracellular vesicles, have emerged as promising carriers in drug delivery due to their ability to bypass biological barriers, low toxicity, high stability, and intrinsic targeting capabilities. Mesenchymal stem-cell-derived exosomes (EXOMSC), with their natural tropism toward the tumor microenvironment, offer an ideal platform for enhancing therapeutic cargo delivery. In this study, we demonstrate an approach where red-emission chlorophyll-based carbon dots (Chl-CDs) were encapsulated within EXOMSC through a cell-driven uptake mechanism, creating CD@EXOMSC. These exosomes achieved superior photodynamic therapy (PDT) efficacy, requiring 40 times less nanomaterial compared to freestanding Chl-CDs. Mechanistic insights from glioblastoma cell miRNA profiling revealed that the enhanced efficacy was mediated by the regulation of efflux transporter genes, oxidative stress responses, and endocytosis pathways. This work highlights the synergistic potential of combining photosensitizers and miRNA-rich exosomes to achieve targeted and sustained therapeutic delivery, paving the way for a multifaceted approach in cancer therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Nanomedical approaches to deplete intracellular glutathione in oncology

  • Bonet-Aleta, Javier
  • Hueso, Jose L.
  • Mosseri, Andrea
  • Santamaria, Jesus
Glutathione (GSH) plays a critical role in maintaining redox homeostasis and conferring chemoresistance to cancer cells, making it an attractive target for therapeutic intervention. Recent advances in nanomedicine have led to the development of diverse nanostructures capable of depleting GSH, either stoichiometrically or catalytically. These systems exploit the elevated GSH demand in tumors to selectively disrupt redox balance, enhancing reactive oxygen species (ROS) accumulation and improving the efficacy of conventional therapies. Approaches include metal-based nanocatalysts, GSH-responsive prodrugs, and stimuli-activated platforms using light or ultrasound for spatiotemporal control. Despite promising preclinical outcomes, key challenges remain, including limited mechanistic understanding, variability in GSH sensitivity across cancer types, and a lack of standardized assays to evaluate GSH-depleting efficiency. Addressing these gaps will require cross-disciplinary efforts bridging materials science, chemical biology, and catalysis. Such integration is essential for translating GSH-targeting nanomedicines into effective clinical tools against drug-resistant malignancies. This perspective provides an overview of some of the most promising nanomaterials explored in the current state of the art and discusses the main strategies and challenges relevant to future clinical translation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Stimuli‐responsive silsesquioxane nanozymes for organocatalysis in water and prodrug activation in cells

  • Zahid, Rabia
  • Lázaro, Ariadna
  • Moreno-Alcántar, Guillermo
  • Sancho-Albero, María
  • Picchetti, Pierre
Synthetic nanozymes have emerged as promising alternatives to natural enzymes for catalytic and therapeutic applications, yet their limited stability, aqueous compatibility, and catalytic scope impede broader utilization. Here, we report a mild, one‐step sol–gel synthesis that yields ultrasmall, water‐stable octa‐amino silsesquioxanes functioning as metal‐free nanozymes. These minimalistic nanostructures exhibit aldolase‐like organocatalytic activity in water and enable dynamic, stimuli‐responsive modulation of catalysis through reversible supramolecular aggregation and disaggregation triggered by specific chemical inputs, thus forming a multifunctional platform for tunable catalysis and biomedical applications. Structural simplicity, stability, and functional versatility together permit tunable, enzyme‐like catalysis in water without auxiliary surfactants or phase‐transfer additives. Furthermore, the nanozymes display high biocompatibility and efficient cellular internalization, enabling their use in living cells, for instance, as intracellular prodrug activators via retro‐aldol activation of a doxorubicin prodrug in human glioblastoma and metastatic melanoma cells, resulting in selective cytotoxicity. This system provides a cost‐effective, sustainable, and scalable platform for water‐compatible, metal‐free organocatalysis that bridges abiotic catalysis and biological function. These findings demonstrate how rationally designed silsesquioxane frameworks can emulate natural enzyme reactivity while integrating adaptive, stimuli‐responsive behavior, broadening the applicability of synthetic nanozymes to catalytic and therapeutic contexts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Copper–Collagen Interactions Regulate the Mechanical and Invasive Properties of Tumor Spheroids

  • Guerrero-López, Paula
  • Garcia-Peiro, Jose I.
  • Hornos, Felipe
  • Hueso, Jose L.
  • Santamaria, Jesus
  • Garcia-Aznar, J. Manuel
Copper is a key trace element with established cytotoxic properties, yet its interactions with the extracellular matrix and their implications for the evolution of 3D culture models remain poorly understood. Here, we study how copper entrapped in collagen can regulate the structural and invasive properties of 3D tumor spheroids. Our findings reveal that copper influences cytoskeletal organization, protrusion dynamics, and epithelial–mesenchymal transitions. Interestingly, we also highlight its dual capacity to either suppress or enhance invasive behavior depending on the context of exposure. These results position copper as a context‐dependent modulator of tumor progression and underscore the importance of dose and timing in determining therapeutic outcomes. By integrating a physiologically relevant 3D model, this study provides new insights into copper–ECM interactions and identifies potential strategies to exploit them for cancer therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ultrasmall Platinum Nanoparticles for Radiation‐Enhanced Cancer Therapy

  • Encinas-Gimenez, Miguel
  • Garcia-Peiro, Jose I.
  • Hueso, Jose L.
  • Caleiras, Eduardo
  • Notario, Laura
  • Hornos, Felipe
  • Martin-Duque, Pilar
  • De la Vieja, Antonio
  • Santamaria, Jesus
Despite decades of intense research, cancer remains a major global health challenge, with a clear need for new and more efficient therapies. Among emerging approaches, high atomic number (Z) nanomaterials capable of modulating the interaction between radiation and matter have attracted growing interest as radiotherapy enhancers. In this work, ultra‐small Platinum‐based nanoparticles with a metallic core diameter of 2–3 nm were synthesized from H2PtCl6 using polyvinylpyrrolidone as stabilizer. This nanomaterial exhibits low acute toxicity, catalase‐like activity and enhances DNA damage under pre‐clinical X‐ray irradiation, increasing the antitumoral effect of X‐ray alone. In vitro and in vivo studies, including intratumoral and intravenous administration, demonstrate improved tumor control and prolonged survival without detectable systemic toxicity under the tested conditions, establishing ultra‐small Pt‐nanoparticles as efficient materials for radiotherapy enhancement.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Immobilization of glucose oxidase and catalase on magnetite nanoparticles as functional catalyst supports

  • Valls-Chiva, Angeles
  • Hornos, Felipe
  • Hueso, Jose L.
  • Martín-Pardillos, Ana
  • Santamaria, Jesus
In this work, we have prepared magnetite nanoparticles (MNPs) coated with polyethylenimine (PEI) to obtain a positively charged surface and showed their suitability as functional supports to successfully immobilize glucose oxidase (GOx) and catalase (CAT) enzymes. We have compared two immobilization strategies, namely electrostatic binding and covalent attachment mediated by glutaraldehyde cross-linking. To quantify the amount of immobilized enzyme (qmax), we have developed a methodological approach that minimizes the dependence of the qmax value on the equilibrium constant of the adsorption process (K). Catalytic studies showed high retention of enzymatic activity (100% for covalent binding and 75% for electrostatic binding), indicating that the immobilization protocol preserves the native conformation of the enzyme. Furthermore, the covalent strategy demonstrated stable binding even when the nanohybrid was subjected to extreme conditions (pH 3), retaining 91% of the enzyme on the surface, compared to 6% when immobilized electrostatically. These results highlight the importance of surface engineering in the design of magnetic biocatalysts for potential application in starvation or oxygen generation therapies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy

  • Sancho-Albero, Maria
  • Martín-Pardillos, Ana
  • Hueso, Jose L.
  • Sebastián, Víctor
  • Santamaria, Jesús
Three decades after the approval of the first cancer nanomedicine, low (<1%) tumor delivery remains the central unsolved challenge in nanoparticle (NP)-based therapy. This barrier has prompted a research shift toward biologically derived delivery systems able to reduce immune clearance while preserving tumor-homing capabilities. In particular, extracellular vesicles (EVs) seem obvious candidates on account of their intrinsic biocompatibility, cell-specific tropism, and biological functionality. In this mini-review, we critically analyze EVs as nanoparticle delivery vectors in cancer therapy. We describe current EV engineering approaches, including loading methodologies, surface modification strategies, and the development of artificial or biomimetic EVs, highlighting technical, scalability, and characterization challenges. We also summarize key in vitro and in vivo results, addressing encapsulation strategy, biodistribution, and therapeutic outcomes. From this discussion, we outline research needs that must be addressed to develop EV–NP hybrids as tools to overcome the delivery challenge in cancer.